FDA Oncology Division Director Says Goal to Make Review Process “Predictable”
Three Bomb Threats At NIH In One Week result In Evacuations, Investigations
FDA Oncology Division To Develop Papers On Expectations for New Drugs
DeLap: Seven Years In industry Provided View Of Pressures On Drug Developers
With workload Up, Oncology Division To Add More Staff
Trending Stories
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Cancer Center at Illinois is recognized as NCI Basic Cancer Center, becoming the first new institution to earn this designation in 40 years
- Most Favored Nation drug pricing could put China on top
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- Self-collection kits for HPV are among innovations adding momentum to eradication of cervical cancer
A kit for at-home unsupervised self-collection clears FDA finish line









